UBE4B gene expression is strongly associated with neuroblastoma patient outcomes [37, 38], and UBE4B ubiquitin ligase activity on the endosomal membrane surface is required for appropriate EGFR trafficking and lysosomal degradation in neuroblastoma cells [39]. Here, EGFR is linked to neuroblastoma.